Could your job give you skin cancer? new study investigates
NCT ID NCT07251335
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This observational study in Italy will examine the link between work-related sun exposure and melanoma. Researchers will interview 300 people (120 with melanoma, 180 without) about their job history, sun habits, and protection use. The goal is to better understand how outdoor work contributes to melanoma and to improve reporting of these cases as occupational diseases.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help identify outdoor work as a key risk factor for certain melanomas, leading to better prevention and occupational disease recognition.
- What could go wrong
- This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to other regions or populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dipartimento di Scienze Biomediche, Metaboliche e Neuroscienze
RECRUITINGModena, Mo, 41122, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- E-Learning could sharpen Doctors' eye for skin cancer
- Can a new drug tame advanced solid tumors?
- Can a short Pre-Surgery immunotherapy course replace Long-Term adjuvant treatment for melanoma?
- Can a single tracer light up cancer's first stop? a trial puts a hybrid dye-and-radioactive marker to the test.
- Could a Two-Drug combo reawaken the immune system against resistant cancers?
- New melanoma drug aims to match Keytruda's success